id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ffhd-100	Nicolson, Garth L.; Settineri, Robert; Ellithorpe, Rita	Glycophospholipid Formulation with NADH and CoQ10 Significantly Reduces Intractable Fatigue in Western Blot-Positive ‘Chronic Lyme Disease’ Patients: Preliminary Report	2012		.htm	text/html	619	15	21	No. 3 (2012): March 2012 / Research Articles Glycophospholipid Formulation with NADH and CoQ10 Significantly Reduces Intractable Fatigue in Western Blot-Positive ‘Chronic Lyme Disease’ Patients: Preliminary Report Authors Garth L. Nicolson Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, California 92647 Robert Settineri Sierra Research, Irvine, California 92606 Rita Ellithorpe Tustin Longevity Center, Tustin, California 92780 DOI: https://doi.org/10.31989/ffhd.v2i3.100 Abstract Background: An open label 8-week preliminary study was conducted in a small number of patients to determine if a combination oral supplement containing a mixture of phosphoglycolipids, coenzyme Q10 and microencapsulated NADH and other nutrients could affect fatigue levels in long-term, Western blot-positive, multi-symptom ‘chronic Lyme disease’ patients (also called ‘post-treatment Lyme disease’ or ‘post Lyme syndrome’) with intractable fatigue. Methods: The subjects in this study were 6 males (mean age = 45.1 ± 12.4 years) and 10 females (mean age = 54.6 ± 7.4 years) with ‘chronic Lyme disease’ (determined by multiple symptoms and positive Western blot analysis) that had been symptomatic with chronic fatigue for an average of 12.7 ± 6.6 years.	cache/ffhd-100.htm	txt/ffhd-100.txt